4.4 Article

Pediatric Hospitalizations and ICU Admissions Due to COVID-19 and Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 in England

Related references

Note: Only part of the references are listed.
Article Pediatrics

Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves

Olivia Swann et al.

Summary: This study aimed to investigate the clinical characteristics of hospitalized children and young people with SARS-CoV-2 during the UK's second wave. The results showed that patients in the second wave had lower PEWS, less antibiotic use, and fewer respiratory and cardiovascular support compared to the first wave. However, there was no change in the proportion of patients admitted to critical care. At least 20% of patients in this cohort had asymptomatic/incidental SARS-CoV-2 infection.

PEDIATRIC RESEARCH (2023)

Article Immunology

Lower Risk of Multisystem Inflammatory Syndrome in Children With the Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2

Jonathan M. Cohen et al.

Summary: Little is known about the risk of multisystem inflammatory syndrome in children (MIS-C) with different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. In southeast England, MIS-C rates per confirmed SARS-CoV-2 infections in children aged 0-16 years were 56% lower during prevaccine Delta, 66% lower during postvaccine Delta, and 95% lower during the Omicron period.

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

SARS-CoV-2 variants and the risk of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 among children in Germany

A. L. Sorg et al.

Summary: This study investigated the relationship between the risk of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in children and the predominance of different SARS-CoV-2 variants of concern (VOC) over time. The results showed a significant correlation between the prevalence of different VOCs during different phases of the pandemic and the risk of PIMS-TS, with the highest risk associated with the Alpha variant and the lowest risk associated with the Omicron variant. The study also found that vaccination against SARS-CoV-2 did not have a significant impact on the risk of children developing PIMS-TS.

INFECTION (2023)

Article Biochemistry & Molecular Biology

Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year

J. L. Ward et al.

Summary: The risk of intensive care unit admission among children with COVID-19 or PIMS-TS is influenced by age, ethnicity, and comorbidities, which can guide treatment and prevention strategies.

NATURE MEDICINE (2022)

Article Biochemistry & Molecular Biology

Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year

Clare Smith et al.

Summary: A clinical review of all pediatric deaths in England from March 2020 to February 2021 attributes 25 deaths to SARS-CoV-2 infection and identifies risk factors to guide interventions. These results are important for guiding decisions on shielding and vaccinating children, with factors like age, ethnicity, and comorbidities potentially influencing mortality rates related to SARS-CoV-2.

NATURE MEDICINE (2022)

Article Public, Environmental & Occupational Health

Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, July 2021–January 2022

Kristin J. Marks et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Article Pediatrics

Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study

Jeane Cloete et al.

Summary: South Africa has experienced a significant increase in COVID-19 cases, especially among pediatric patients, with the predominant variant being the SARS-CoV-2 omicron strain. The rise in pediatric COVID-19 cases and hospitalizations has occurred ahead of adult hospitalizations, highlighting the need for ongoing monitoring to understand the long-term effects of the omicron variant on children and adolescents.

LANCET CHILD & ADOLESCENT HEALTH (2022)

Article Medicine, General & Internal

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

Tommy Nyberg et al.

Summary: The Omicron variant shows lower severity compared to Delta, especially in terms of hospital admission and death, with significant variations by age. Unvaccinated cases experience a larger reduction in intrinsic severity, while vaccinated cases experience reduced vaccine effectiveness. Booster vaccination with mRNA vaccines provides over 70% protection against hospitalization and death in breakthrough Omicron infections.

LANCET (2022)

Letter Pediatrics

Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US

Lindsey Wang et al.

Summary: This cohort study evaluates the incidence rates and clinical outcomes of SARS-CoV-2 infection caused by the Omicron and Delta variants in children younger than 5 years in the United States.

JAMA PEDIATRICS (2022)

Editorial Material Pediatrics

Delay in death registration among adolescents and young adults in England and Wales

Joseph L. Ward et al.

LANCET CHILD & ADOLESCENT HEALTH (2022)

Letter Pediatrics

Risk of hospitalisation and death in children with SARS-CoV-2 delta (B.1.612.2) infection

Simon Thelwall et al.

LANCET CHILD & ADOLESCENT HEALTH (2022)

Letter Medicine, General & Internal

Effects of Vaccination and Previous Infection on Omicron Infections in Children

Dan-Yu Lin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Review Medicine, General & Internal

Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis

Rachel Harwood et al.

Summary: This study aimed to describe pre-existing factors associated with severe disease and death in hospitalized children and young people with SARS-CoV-2 infection. The study found that infants, teenagers, individuals with cardiac or neurological conditions, those with two or more comorbid conditions, and the obese were at the highest risk for severe disease or death.

ECLINICALMEDICINE (2022)

Letter Infectious Diseases

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark

Peter Bager et al.

LANCET INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Increased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load

Frederik Plesner Lyngse et al.

Summary: The B.1.1.7 lineage (Alpha variant) became dominant in early 2021 with a higher transmissibility, infecting more households. The increased transmissibility of B.1.1.7 compared to other lineages is 1.5-1.7 times higher, with a multiplicative effect across age and viral load.

NATURE COMMUNICATIONS (2021)

Article Pediatrics

Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance

Chris Gale et al.

Summary: This study aimed to describe the incidence, characteristics, transmission, and outcomes of SARS-CoV-2 infection in neonates who received inpatient hospital care in the UK. The findings showed that neonatal SARS-CoV-2 infection was uncommon in babies admitted to hospital, with low likelihood of infection following birth to a mother with perinatal SARS-CoV-2 infection and rare possible vertical transmission. The high proportion of babies from Black, Asian, or minority ethnic groups requires further investigation.

LANCET CHILD & ADOLESCENT HEALTH (2021)

Article Infectious Diseases

Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study

Peter Bager et al.

Summary: The study conducted in Denmark found that individuals infected with the B.1.1.7 lineage of SARS-CoV-2 had a higher risk of hospitalisation for COVID-19 compared to those with other lineages. While the overall number of hospitalisations decreased during the study period, the proportion of individuals infected with B.1.1.7 significantly increased. The findings suggest implications for hospital preparedness and understanding the impact of the epidemic in areas with the dominant presence of B.1.1.7.

LANCET INFECTIOUS DISEASES (2021)

Article Biology

Real-time nowcasting and forecasting of COVID-19 dynamics in England: the first wave

Paul Birrell et al.

Summary: England has seen a significant reduction in virus transmission due to lockdown measures, especially in London where the impact was the largest. However, from June onwards, there has been a gradual increase in infections, with some regions showing a probability of epidemic growth exceeding 5%. It is estimated that at least 8% of the population has been infected, with a higher proportion in London at 17%.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2021)